Test for Creatine Kinase Isoenzyme-MB
- UID
- IMP/MD/2018/000203_3fbcd8564541c23d2ee9876d86b51e3f_09ea8b9f7abb49855dd50048cc95ccb1
- Device class
- Class B
- Brand name
- QDx Instacheck™ Cortisol
- License holder
- DiaSys Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- QDx Instacheck™ CK-MB along with QDx Instacheck™ Reader is fluorescence Immunoassay (QDx Instacheck™ Cortisol) for the quantitative determination of Creatine Kinase Isoenzyme-MB (QDx Instacheck™ Cortisol) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (QDx Instacheck™ Cortisol) and acute coronary syndrome (QDx Instacheck™ Cortisol)
Test for Creatine Kinase Isoenzyme-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_3fbcd8564541c23d2ee9876d86b51e3f_09ea8b9f7abb49855dd50048cc95ccb1. This device is marketed under the brand name QDx Instacheck™ Cortisol. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.